SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 8.02 |
Enterprise Value ($M) | 19.12 |
Book Value ($M) | 15.52 |
Book Value / Share | 1.01 |
Price / Book | 0.52 |
NCAV ($M) | -8.97 |
NCAV / Share | -0.58 |
Price / NCAV | -0.89 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.49 |
Return on Assets (ROA) | -0.50 |
Return on Equity (ROE) | -0.66 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.06 |
Current Ratio | 1.10 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 4.34 |
Assets | 28.82 |
Liabilities | 13.30 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.02 |
Operating Income | -13.84 |
Net Income | -14.86 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -5.81 |
Cash from Investing | -0.13 |
Cash from Financing | 8.03 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D | Chun-Hsien Tsai | 8.31 | ||
13D | Ting Chuan Lee | 7.20 | ||
13D/A | Ainos Inc | 10.68 | 0.00 | |
13D/A | Advanced Semiconductor Engineering Inc | 17.00 | 36.19 | |
13D | Taiwan Carbon Nano Technology Corp | 40.23 | ||
13D/A | Amarillo Biosciences Inc | 63.36 | 76.37 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
344,109 | 1,163,737 | 29.57 | |
69,567 | 114,784 | 60.61 | |
23,980 | 81,629 | 29.38 | |
44,492 | 128,877 | 34.52 | |
28,519 | 93,264 | 30.58 | |
(click for more detail) |
Similar Companies | |
---|---|
ADTX – Aditxt, Inc. | ADVM – Adverum Biotechnologies, Inc. |
AGEN – Agenus Inc. | AKAN – Akanda Corp. |
AKBA – Akebia Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io